Module 7 - Ae3 RFLB
Module 7 - Ae3 RFLB
COLLEGE DEPARTMENT
MODULE 7
Subject:
AE3-RFLB – REGULATORY FRAMEWORK AND LEGAL ISSUES IN BUSINESS
This material has been developed in support to the Higher Education Program implementation.
Materials included in this module are owned by the respective copyright holders. AISAT College –
Dasmariñas, the publisher and author do not represent nor claim ownership over them.
This material will be reproduced for educational purposes and can be modified for the purpose of
translation into another language provided that the source must be clearly acknowledged. Derivatives of
the work including creating an edited version, enhancement or a supplementary work are permitted
provided all original works are acknowledged and the copyright is attributed. No work may be derived
from this material for commercial purposes and profit.
Unit Intellectual Property Code
Module The Law on Patents
REGULATORY FRAMEWORK AND LEGAL Page |2
AE3-RFLB Units: 3
ISSUES IN BUSINESS
Learning objectives.
Patentability
Patentable Inventions.
Any technical solution of a problem in any field of human activity which is new, involves an
inventive step and is industrially applicable shall be patentable. It may be, or may relate to, a product, or
process, or an improvement of any of the foregoing.
Non-Patentable Inventions.
The following shall be excluded from patent protection:
1. Discoveries, scientific theories and mathematical methods, and in the case of drugs and medicines,
the mere discovery of a new form or new property of a known substance which does not result in the
enhancement of the known efficacy of that substance, or the mere discovery of any new property or
new use for a known substance, or the mere use of a known process unless such known process
results in a new product that employs at least one new reactant.
For the purpose of this clause, salts, esters, ethers, polymorphs, metabolites, pure form, particle
size, isomers, mixtures of isomers, complexes, combinations, and other derivatives of a known
substance shall be considered to be the same substance, unless they differ significantly in properties
with regard to efficacy;
SUBJECT TEACHER: APPROVED FOR IMPLEMENTATION:
MODULE 7th
MIDTERM
7 Meeting MS. EMERITA S.MERCADAL MR. WILBERT A. MAÑUSCA
Subject Teacher School Director
Unit Intellectual Property Code
Module The Law on Patents
REGULATORY FRAMEWORK AND LEGAL Page |3
AE3-RFLB Units: 3
ISSUES IN BUSINESS
2. Schemes, rules and methods of performing mental acts, playing games or doing business, and
programs for computers;
3. Methods for treatment of the human or animal body by surgery or therapy and diagnostic methods
practiced on the human or animal body. This provision shall not apply to products and composition
for use in any of these methods;
4. Plant varieties or animal breeds or essentially biological process for the production of plants or
animals. This provision shall not apply to micro-organisms and non-biological and microbiological
processes.
Provisions under this subsection shall not preclude Congress to consider the enactment of a law
providing sui generis protection of plant varieties and animal breeds and a system of community
intellectual rights protection:
5. Aesthetic creations; and
6. Anything which is contrary to public order or morality. (Sec. 8, R.A. No. 165a)
Novelty
An invention shall not be considered new if it forms part of a prior art. (Sec. 9, R.A. No. 165a)
Non-Prejudicial Disclosure.
1. The disclosure of information contained in the application during the twelve (12) months preceding
the filing date or the priority date of the application shall not prejudice the applicant on the ground
of lack of novelty if such disclosure was made by:
(a) The inventor;
(b) A patent office and the information was contained (a) in another application filed by the inventor
and should not have been disclosed by the office, or (b) in an application filed without the
knowledge or consent of the inventor by a third party which obtained the information directly or
indirectly from the inventor; or
(c) A third party which obtained the information directly or indirectly from the inventor.
2. For the purposes of Subsection 25.1, “inventor” also means any person who, at the filing date of
application, had the right to the patent. (n)
Inventive Step.
1. An invention involves an inventive step if, having regard to prior art, it is not obvious to a person
skilled in the art at the time of the filing date or priority date of the application claiming the
invention. (n)
2. In the case of drugs and medicines, there is no inventive step if the invention results from the mere
discovery of a new form or new property of a known substance which does not result in the
enhancement of the known efficacy of that substance, or the mere discovery of any new property or
new use for a known substance, or the mere use of a known process unless such known process
results in a new product that employs at least one new reactant.
Industrial Applicability.
An invention that can be produced and used in any industry shall be industrially applicable. (n)
Right to a Patent
Right to a Patent.
The right to a patent belongs to the inventor, his heirs, or assigns. When two (2) or more
persons have jointly made an invention, the right to a patent shall belong to them jointly. (Sec. 10, R.A.
No. 165a)
Right of Priority.
An application for patent filed by any person who has previously applied for the same invention
in another country which by treaty, convention, or law affords similar privileges to Filipino citizens, shall
be considered as filed as of the date of filing the foreign application: Provided, That:
(a) the local application expressly claims priority;
(b) it is filed within twelve (12) months from the date the earliest foreign application was filed;
and
(c) a certified copy of the foreign application together with an English translation is filed within
six (6) months from the date of filing in the Philippines. (Sec. 15, R.A. No. 165a)
Patent Application
The Application.
1. The patent application shall be in Filipino or English and shall contain the following:
(a) A request for the grant of a patent;
(b) A description of the invention;
(c) Drawings necessary for the understanding of the invention;
(d) One or more claims; and
(e) An abstract.
2. No patent may be granted unless the application identifies the inventor. If the applicant is not the
inventor, the Office may require him to submit said authority. (Sec. 13, R.A. No. 165a)
The Request.
The request shall contain a petition for the grant of the patent, the name and other data of the
applicant, the inventor and the agent and the title of the invention. (n)
Disclosure.
The application shall disclose the invention in a manner sufficiently clear and complete for it to
be carried out by a person skilled in the art.
Where the application concerns a microbiological process or the product thereof and involves
the use of a micro-organism which cannot be sufficiently disclosed in the application in such a way as to
enable the invention to be carried out by a person skilled in the art, and such material is not available to
the public, the application shall be supplemented by a deposit of such material with an international
depository institution.
Description.
The Regulations shall prescribe the contents of the description and the order of presentation.
(Sec. 14, R.A. No. 165a)
The Claims.
The application shall contain one (1) or more claims which shall define the matter for which
protection is sought. Each claim shall be clear and concise, and shall be supported by the description.
36.2. The Regulations shall prescribe the manner of the presentation of claims. (n)
The Abstract.
SUBJECT TEACHER: APPROVED FOR IMPLEMENTATION:
MODULE 7th
MIDTERM
7 Meeting MS. EMERITA S.MERCADAL MR. WILBERT A. MAÑUSCA
Subject Teacher School Director
Unit Intellectual Property Code
Module The Law on Patents
REGULATORY FRAMEWORK AND LEGAL Page |6
AE3-RFLB Units: 3
ISSUES IN BUSINESS
The abstract shall consist of a concise summary of the disclosure of the invention as contained in
the description, claims and drawings in preferably not more than one hundred fifty (150) words. It must
be drafted in a way which allows the clear understanding of the technical problem, the gist of the
solution of that problem through the invention, and the principal use or uses of the invention. The
abstract shall merely serve for technical information. (n)
Unity of Invention.
1. The application shall relate to one invention only or to a group of inventions forming a single general
inventive concept.
2. If several independent inventions which do not form a single general inventive concept are claimed in
one application, the Director may require that the application be restricted to a single invention. A
later application filed for an invention divided out shall be considered as having been filed on the
same day as the first application: Provided, That the later application is filed within four (4) months
after the requirement to divide becomes final, or within such additional time, not exceeding four (4)
months, as may be granted: Provided, further, That each divisional application shall not go beyond
the disclosure in the initial application.
3. The fact that a patent has been granted on an application that did not comply with the requirement
of unity of invention shall not be a ground to cancel the patent. (Sec. 17, R.A. No. 165a)
If the deficiencies are not remedied within the prescribed time limit, the application shall be
considered withdrawn. (n)
Formality Examination.
1. After the patent application has been accorded a filing date and the required fees have been paid on
time in accordance with the Regulations, the applicant shall comply with the formal requirements
specified by Section 32 and the Regulations within the prescribed period, otherwise the application
shall be considered withdrawn.
2. The Regulations shall determine the procedure for the re-examination and revival of an application as
well as the appeal to the Director of Patents from any final action by the examiner. (Sec. 16, R.A. No.
165a)
Amendment of Application.
An applicant may amend the patent application during examination: Provided, That such
amendment shall not include new matter outside the scope of the disclosure contained in the
application as filed. (n)
Grant of Patent.
1. If the application meets the requirements of this Act, the Office shall grant the patent: Provided, That
all the fees are paid on time.
2. If the required fees for grant and printing are not paid in due time, the application shall be deemed to
be withdrawn.
3. A patent shall take effect on the date of the publication of the grant of the patent in the IPO Gazette.
(Sec. 18, R.A. No. 165a)
1. The final order of refusal of the examiner to grant the patent shall be appealable to the Director in
accordance with this Act.
2. The Regulations shall provide for the procedure by which an appeal from the order of refusal from the
Director shall be undertaken. (n)
Contents of Patent.
The patent shall be issued in the name of the Republic of the Philippines under the seal of the
Office and shall be signed by the Director, and registered together with the description, claims, and
drawings, if any, in books and records of the Office. (Secs. 19 and 20, R.A. No. 165a)
Term of Patent.
The term of a patent shall be twenty (20) years from the filing date of the application. (Sec. 21,
R.A. No. 165a)
Annual Fees.
1. To maintain the patent application or patent, an annual fee shall be paid upon the expiration of four
(4) years from the date the application was published pursuant to Section 44 hereof, and on each
subsequent anniversary of such date. Payment may be made within three (3) months before the due
date. The obligation to pay the annual fees shall terminate should the application be withdrawn,
refused, or cancelled.
2. If the annual fee is not paid, the patent application shall be deemed withdrawn or the patent
considered as lapsed from the day following the expiration of the period within which the annual
fees were due. A notice that the application is deemed withdrawn or the lapse of a patent for non-
payment of any annual fee shall be published in the IPO Gazette and the lapse shall be recorded in
the Register of the Office.
3. A grace period of six (6) months shall be granted for the payment of the annual fee, upon payment of
the prescribed surcharge for delayed payment. (Sec. 22, R.A. No. 165a)
Surrender of Patent.
1. The owner of the patent, with the consent of all persons having grants or licenses or other right, title
or interest in and to the patent and the invention covered thereby, which have been recorded in the
Office, may surrender his patent or any claim or claims forming part thereof to the Office for
cancellation.
2. A person may give notice to the Office of his opposition to the surrender of a patent under this
section, and if he does so, the Bureau shall notify the proprietor of the patent and determine the
question.
3. If the Office is satisfied that the patent may properly be surrendered, he may accept the offer and, as
from the day when notice of his acceptance is published in the IPO Gazette, the patent shall cease to
have effect, but no action for infringement shall lie and no right compensation shall accrue for any
use of the patented invention before that day for the services of the government. (Sec. 24, R.A. No.
165a)
On request of any interested person and payment of the prescribed fee, the Director is
authorized to correct any mistake in a patent of a formal and clerical nature, not incurred through the
fault of the Office. (Sec. 26, R.A. No. 165a)
Changes in Patents.
1. The owner of a patent shall have the right to request the Bureau to make the changes in the patent in
order to:
(a) Limit the extent of the protection conferred by it;
(b) Correct obvious mistakes or to correct clerical errors; and
(c) Correct mistakes or errors, other than those referred to in letter (b), made in good faith: Provided,
That where the change would result in a broadening of the extent of protection conferred by the
patent, no request may be made after the expiration of two (2) years from the grant of a patent
and the change shall not affect the rights of any third party which has relied on the patent, as
published.
2. No change in the patent shall be permitted under this section, where the change would result in the
disclosure contained in the patent going beyond the disclosure contained in the application filed.
3. If, and to the extent to which the Office changes the patent according to this section, it shall publish
the same. (n)
Cancellation of Patents.
1. Any interested person may, upon payment of the required fee, petition to cancel the patent or any
claim thereof, or parts of the claim, on any of the following grounds:
(a) That what is claimed as the invention is not new or patentable;
(b) That the patent does not disclose the invention in a manner sufficiently clear and complete for it
to be carried out by any person skilled in the art; or
(c) That the patent is contrary to public order or morality.
2. Where the grounds for cancellation relate to some of the claims or parts of the claim, cancellation
may be effected to such extent only. (Secs. 28 and 29, R.A. No. 165a)
Notice of Hearing.
Upon filing of a petition for cancellation, the Director of Legal Affairs shall forthwith serve notice
of the filing thereof upon the patentee and all persons having grants or licenses, or any other right, title
or interest in and to the patent and the invention covered thereby, as appears of record in the Office,
and of notice of the date of hearing thereon on such persons and the petitioner. Notice of the filing of
the petition shall be published in the IPO Gazette. (Sec. 31, R.A. No. 165a)
Committee of Three.
In cases involving highly technical issues, on motion of any party, the Director of Legal Affairs
may order that the petition be heard and decided by a committee composed of the Director of Legal
Affairs as chairman and two (2) members who have the experience or expertise in the field of
technology to which the patent sought to be cancelled relates. The decision of the committee shall be
appealable to the Director General. (n)
References:
1. Republic Act No. 8293, Series of 1997. An Act Prescribing the Intellectual Property Code And
Establishing The Intellectual Property Office, Providing For Its Powers And Functions, And For
Other Purposes. Official Gazette Of The Republic Of The Philippines
https://www.officialgazette.gov.ph/1997/06/06/republic-act-no-8293/
SELF-CHECK MD -1.1.1
“The Intellectual Property Office”
1. .
2. .
3. .